Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Myelocytic Leukemia (CML) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chronic Myelocytic Leukemia (CML) till 2023.

Key Coverage and Benefits

- The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Myelocytic Leukemia (CML) market.

- Identifying patient populations in the global "Chronic Myelocytic Leukemia (CML)market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the best opportunities for Chronic Myelocytic Leukemia (CML) therapeutics in each of the markets covered.

- To understand the future market competition in the global Chronic Myelocytic Leukemia (CML) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

- Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

- It also provides Chronic Myelocytic Leukemia (CML) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Chronic Myelocytic Leukemia (CML)overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Chronic Myelocytic Leukemia (CML)Market
Global Epidemiology of Chronic Myelocytic Leukemia (CML)Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1:Drug Description
Table 2:Drug, Marketed Details United States (US)
Table 3:Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4:Drug, Patent Details for US
Table 5:Chronic Myelocytic Leukemia (CML)Drug Sales (USD Millions)-2023
Table 6:Global Epidemiology of Chronic Myelocytic Leukemia (CML)(2013-2023)
Table 7:Chronic Myelocytic Leukemia (CML)Global Market (USD Millions), (2013-2015)
Table 8:Chronic Myelocytic Leukemia (CML)Global Market (USD Millions), (2016-2023)
Table 9:Chronic Myelocytic Leukemia (CML)US Market (USD Millions), (2013-2015)
Table 10: Chronic Myelocytic Leukemia (CML)US Market (USD Millions), (2016-2023)
Table 11: Chronic Myelocytic Leukemia (CML)Germany Market (USD Millions), (2013-2015)
Table 12: Chronic Myelocytic Leukemia (CML)Germany Market (USD Millions), (2016-2023)
Table 13: Chronic Myelocytic Leukemia (CML)United Kingdom Market (USD Millions), (2013-2015)
Table 14: Chronic Myelocytic Leukemia (CML)United Kingdom Market (USD Millions), (2016-2023)
Table 15: Chronic Myelocytic Leukemia (CML)France Market (USD Millions), (2013-2015)
Table 16: Chronic Myelocytic Leukemia (CML)France Market (USD Millions), (2016-2023)
Table 17: Chronic Myelocytic Leukemia (CML)Italy Market (USD Millions), (2013-2015)
Table 18: Chronic Myelocytic Leukemia (CML)Italy Market (USD Millions), (2016-2023)
Table 19: Chronic Myelocytic Leukemia (CML)Spain Market (USD Millions), (2013-2015)
Table 20: Chronic Myelocytic Leukemia (CML)Spain Market (USD Millions), (2016-2023)
Table 21: Chronic Myelocytic Leukemia (CML)Japan Market (USD Millions), (2013-2015)
Table 22: Chronic Myelocytic Leukemia (CML)Japan Market (USD Millions), (2016-2023)
Table 23: Chronic Myelocytic Leukemia (CML)ROW Market (USD Millions), (2013-2015)
Table 24: Chronic Myelocytic Leukemia (CML)ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Chronic Myelocytic Leukemia (CML)Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Chronic Myelocytic Leukemia (CML)(2013-2023)
Figure 3: Chronic Myelocytic Leukemia (CML)Global Market (USD Millions), (2013-2015)
Figure 4: Chronic Myelocytic Leukemia (CML)Global Market (USD Millions), (2016-2023)
Figure 5: Chronic Myelocytic Leukemia (CML)US Market (USD Millions), (2013-2015)
Figure 6: Chronic Myelocytic Leukemia (CML)US Market (USD Millions), (2016-2023)
Figure 7: Chronic Myelocytic Leukemia (CML)Germany Market (USD Millions), (2013-2015)
Figure 8: Chronic Myelocytic Leukemia (CML)Germany Market (USD Millions), (2016-2023)
Figure 9: Chronic Myelocytic Leukemia (CML)United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Chronic Myelocytic Leukemia (CML)United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Chronic Myelocytic Leukemia (CML)France Market (USD Millions), (2013-2015)
Figure 12: Chronic Myelocytic Leukemia (CML)France Market (USD Millions), (2016-2023)
Figure 13: Chronic Myelocytic Leukemia (CML)Italy Market (USD Millions), (2013-2015)
Figure 14: Chronic Myelocytic Leukemia (CML)Italy Market (USD Millions), (2016-2023)
Figure 15: Chronic Myelocytic Leukemia (CML)Spain Market (USD Millions), (2013-2015)
Figure 16: Chronic Myelocytic Leukemia (CML)Spain Market (USD Millions), (2016-2023)
Figure 17: Chronic Myelocytic Leukemia (CML)Japan Market (USD Millions), (2013-2015)
Figure 18: Chronic Myelocytic Leukemia (CML)Japan Market (USD Millions), (2015-2023)
Figure 19: Chronic Myelocytic Leukemia (CML)ROW Market (USD Millions), (2013-2015)
Figure 20: Chronic Myelocytic Leukemia (CML)ROW Market (USD Millions), (2016-2023)
  • Global Circulating Tumor Cells Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 08-Dec-2016        Price: US 3480 Onwards        Pages: 110
    This report mainly covers Circulating Tumor Cells products, by types (CTC enrichment, CTC detection and CTC analysis), by applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others).Scope of the Report:This report focuses on the Circulating Tumor Cells in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type ......
  • Metastatic Breast Cancer - Pipeline Review, H2 2016
    Published: 07-Dec-2016        Price: US 2500 Onwards        Pages: 1096
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.Metastatic breast cancer (also called Stage IV or Advanced) is a stage of breast cancer in which cancer cells break away from the tumor in the breast, spread to other parts of the body and keep growing. Symptoms of metastatic breast cancer includes severe, progressive pain, an......
  • United States Testicular Implant Market Report 2016
    Published: 05-Dec-2016        Price: US 3800 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Testicular Implant Revenue, means the sales value of Testicular Implant This report studies sales (consumption) of Testicular Implant in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - AART - Allied Biomedical - Coloplast - Nagor - Polytech Health & Aesthetics - Promedon - Sebbin - UROMED ......
  • United States Non-small Cell Lung Cancer Therapeutics Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 117
    Notes: Sales, means the sales volume of Non-small Cell Lung Cancer Therapeutics Revenue, means the sales value of Non-small Cell Lung Cancer Therapeutics This report studies sales (consumption) of Non-small Cell Lung Cancer Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - GlaxoSmithKline - Menarini - Sanofi - ZIOPHARM Onco......
  • Vulvar Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 76
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vulvar Cancer - Pipeline Review, H2 2016, provides an overview of the Vulvar Cancer (Oncology) pipeline landscape.Vulvar cancer is a rare type of cancer. It forms in a woman's external genitals, called the vulva. The cancer usually develops slowly over several years. First, precancerous cells grow on vulvar skin. This is called vulvar intraepithelial neoplasia (VIN), or dysplasia. Not all VIN cases turn into c......
  • Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 477
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.The acute myeloid leukemia cells which resist treatment are referred to as refractory acute myeloid leukemia. Signs and symptoms includes pale skin, swollen gums, minor infections, such as perianal sores, loss of appetite and weight loss and aches or discomfo......
  • Small-Cell Lung Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 588
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.Small cell lung cancer (SCLC) is a fast-growing type of lung cancer. It spreads much more quickly than non-small cell lung cancer. SCLC is the most aggressive form of lung cancer. It usually starts in the breathing tubes (bronchi) in the center of the chest. These tumors often spr......
  • Gallbladder Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 74
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer - Pipeline Review, H2 2016, provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape.Gallbladder cancer is a cancer that starts in the gallbladder. Symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark urine and weight loss. Risk factors include overweight, age, family history, gallstones, gender and choledochal cysts......
  • Vaginal Cancer - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 68
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer - Pipeline Review, H2 2016, provides an overview of the Vaginal Cancer (Oncology) pipeline landscape.Vaginal cancer is a rare cancer that occurs in vagina. Symptoms includes watery vaginal discharge, a lump or mass in vagina, painful urination, constipation and pelvic pain, vaginal bleeding. Risk factors include age, Smoking, HIV infection and vaginal intraepithelial neoplasia. Treatment include......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs